AURX insider transaction filings
Nuo Therapeutics, Inc. — 21 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-02. Screen AURX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | CLAUSEN PETER — CSO/COO | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | JORDEN DAVID EMERSON — CEO/CFO, Director | Option exercise (M): 162,500 @ $1 · Tax withholding (F): 160,892 @ $1.01 · Option exercise (M): 162,500 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Pittman Scott M. — Director, 10% owner | Option exercise (M): 40,000 @ $1 · Tax withholding (F): 39,604 @ $1.01 · Option exercise (M): 40,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | WINZER C ERIC — Director | Option exercise (M): 40,000 @ $1 · Tax withholding (F): 39,604 @ $1.01 · Option exercise (M): 40,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Mintz Paul — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | JORDEN DAVID EMERSON — CEO/CFO, Director | Grant/award (A): 13,245 @ $1.10 | EDGAR |
| 2026-06-02 | 4 | Pittman Scott M. — Director, 10% owner | Grant/award (A): 17,450 (derivative) @ $1.50 · Disposition to issuer (D): 36,750 (derivative) @ $1.50 · Disposition to issuer (D): 7,516 (derivative) @ $1.50 · Grant/award (A): 17,500 (derivative) @ $1.50 · Grant/award (A): 7,333 (derivative) @ $1.50 | EDGAR |
| 2026-06-02 | 4/A | Pittman Scott M. — Director, 10% owner | Grant/award (A): 30,050 (derivative) @ $1.50 · Grant/award (A): 36,750 (derivative) @ $1.50 · Grant/award (A): 7,516 (derivative) @ $1.50 | EDGAR |
| 2026-01-26 | 4 | Pittman Scott M. — Director, 10% owner | Grant/award (A): 2,050 (derivative) @ $1.50 · Grant/award (A): 1,333 (derivative) @ $1.50 · Grant/award (A): 26,667 (derivative) @ $1.50 · Grant/award (A): 1,750 (derivative) @ $1.50 · Grant/award (A): 35,000 (derivative) @ $1.50 · Grant/award (A): 7,516 (derivative) @ $1.50 | EDGAR |
| 2026-01-05 | 4 | JORDEN DAVID EMERSON — CEO/CFO, Director | Option exercise (M): 125,000 @ $0.40 · Tax withholding (F): 25,381 @ $1.97 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | WINZER C ERIC — Director | Option exercise (M): 68,750 @ $0.40 · Tax withholding (F): 13,750 @ $2 · Option exercise (M): 68,750 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Mintz Paul — Director | Option exercise (M): 50,000 @ $0.40 · Tax withholding (F): 9,091 @ $2.20 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4/A | Mintz Paul — Director | Option exercise (M): 50,000 @ $0.40 · Tax withholding (F): 9,091 @ $2.20 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | JORDEN DAVID EMERSON — CEO/CFO, Director | Sale (S): 200,000 @ $1.50 | EDGAR |
| 2025-08-04 | 4 | WINZER C ERIC — Director | Option exercise (M): 120,313 @ $0.40 · Tax withholding (F): 27,659 @ $1.74 · Option exercise (M): 120,313 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Mintz Paul — Director | Option exercise (M): 87,500 @ $0.40 · Tax withholding (F): 20,115 @ $1.74 · Option exercise (M): 87,500 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | JORDEN DAVID EMERSON — CEO/CFO, Director | Option exercise (M): 100,000 @ $0.40 · Option exercise (M): 92,710 @ $0.40 · Tax withholding (F): 21,313 @ $1.74 · Option exercise (M): 192,710 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | CLAUSEN PETER — CSO/COO | Option exercise (M): 183,853 @ $0.40 · Option exercise (M): 183,853 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4/A | WINZER C ERIC — Director | Option exercise (M): 120,313 @ $0.40 · Tax withholding (F): 27,659 @ $1.74 · Option exercise (M): 120,313 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | Pittman Scott M. — Director, 10% owner | Grant/award (A): 3,946 @ $1.50 | EDGAR |
| 2025-08-01 | 4 | SHEEDY CHARLES E — 10% owner | Purchase (P): 133,333 @ $1.50 | EDGAR |
Recent 8-K events — Nuo Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-10-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers ? 8.01 — Other Events | EDGAR |
| 2025-05-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AURX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →